Arkolith/Insider Trading/PTCT/Form 4

Boulding Mark Elliott

EXEC. VP AND CLOPTC THERAPEUTICS, INC. (PTCT) · full profile →Form 4 · filed May 12, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$280K
Net Open-Market Flow
-$280K
Transactions
8
6 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 8, 2026Option exercise(M)3K$46.54$128K108K
May 8, 2026Sell(S)840$78.23$66K107K
May 8, 2026Sell(S)2K$79.31$151K105K
May 8, 2026Option exercise(M)800$46.54$37K106K
May 8, 2026Sell(S)200$78.00$16K106K
May 8, 2026Sell(S)600$79.28$48K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 8, 2026Option exercise(M)3K—$042K
May 8, 2026Option exercise(M)800—$041K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001578852-26-000014) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML